Corvus Pharmaceuticals, Inc. (CRVS)

NASDAQ

$10.10

$-0.06

(-0.59%)

Regular Market

Corvus Pharmaceuticals, Inc. (CRVS) Live Price Chart

Last updated: ⁦2026-10-21 18:53:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Corvus Pharmaceuticals, Inc. (CRVS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $10.10, with a market capitalization of $811.77M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $6.39 to $26.95. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$811.77M
Open	$10.25
Day's High	$26.95
Day's Low	$0.61
Previous Close	$10.23
Volume	491.13K
Average Volume	992.99K
P/E Ratio	--
52-Week High	$26.95
52-Week Low	$6.39
Dividend Yield	--
Earnings Date	--

Corvus Pharmaceuticals, Inc. (CRVS) Stock Price Today

Corvus Pharmaceuticals, Inc. (CRVS) is currently trading at $10.10 as of 2026-10-21 18:36:14, down 1.27% ($0.13) from the previous close of $10.23

During today's regular trading session, CRVS has traded between $0.61 and $26.95, with a trading volume of 491.13K shares. The current price is near the middle of today's range.

Corvus Pharmaceuticals, Inc. (CRVS) 7-Day Stock Price Change

Over the past seven days, Corvus Pharmaceuticals, Inc. (CRVS) moved from $10.05 to $10.10, representing a gain of 0.50% ($0.05).

The stock traded between $9.21 and $10.59 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.

The average daily volume was 1.04 million shares, down versus the previous seven-day period, indicating lower trading activity.

CRVS 52-Week Price Position

Position in Range: 18.0%

52W Low$6.39

52W High$26.95

CRVS is currently trading at $10.10, placing it 18.0% of the way from its 52-week low of $6.39 to its 52-week high of $26.95. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Corvus Pharmaceuticals, Inc. (CRVS)?

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Corvus Pharmaceuticals, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	37
Exchange	NASDAQ
Company Website	https://www.corvuspharma.com

How to Buy Corvus Pharmaceuticals, Inc. (CRVS) Stock on MEXC

Eligible investors can buy real shares of Corvus Pharmaceuticals, Inc. (CRVS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CRVS and Place Your Order

Open the RealStocks trading page and search for CRVS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Corvus Pharmaceuticals, Inc. (CRVS) stock price today?

Corvus Pharmaceuticals, Inc. (CRVS) is currently trading at $ 10.10, down 1.27% ($0.13) from the previous close of $ 10.23. Intraday prices update in real time during regular trading hours.

2.Is CRVS stock going up or down today?

As of 2026-10-21 18:36:14, CRVS is trading at $ 10.10, down 1.27% ($0.13) from its previous close of $ 10.23. The stock has traded between $ 0.61 and $ 26.95 during today’s regular session. Past price movements do not guarantee future results.

3.What is CRVS pre-market price?

As of 2026-10-21 18:36:14, CRVS is trading at $ 10.13 in pre-market trading, down 0.97% ($0.10) from the previous close of $ 10.23. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CRVS after-hours price?

As of 2026-10-21 18:36:14, CRVS is trading at $ 10.22 in after-hours trading, down 0.15% ($0.02) from the regular-session close of $ 10.23. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CRVS stock trading now?

CRVS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CRVS sit relative to its 52-week high and low?

Over the past 52 weeks, CRVS has traded between a low of $ 6.39 and a high of $ 26.95. At $ 10.10, the stock is positioned 18.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Corvus Pharmaceuticals, Inc. in?

Corvus Pharmaceuticals, Inc. (CRVS) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Corvus Pharmaceuticals, Inc.'s market capitalization and where is it listed?

Corvus Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 811.77M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CRVS valued in terms of P/E ratio and EPS?

CRVS trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.64. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Corvus Pharmaceuticals, Inc. pay a dividend?

Corvus Pharmaceuticals, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.